ERCC1 and small cell lung carcinoma: Our results showed a higher expression of these genes in SCLC patients compared to the healthy controls; of note, patients with low ERCC1 and ERCC5 expression had better mPFS and mOS, while an inverse trend emerged in survival outcomes for ERCC2 expression.